Young Jun Kim | Pharmaceutical Science | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Young Jun Kim | Pharmaceutical Science | Best Researcher Award

professor, Korea university, South Korea

πŸ“Œ Prof. Dr. Young Jun Kim is a distinguished food scientist πŸ₯Ό specializing in functional food, biotechnology, and nutrition. He is a Professor at Korea University (2013–present) and serves as Dean of the Dept. of Food and Biotechnology. He earned his Ph.D. in Food Science from Cornell University (2001), focusing on conjugated linoleic acids (CLA) in dairy products. He has held key positions, including Business Director at Caregen Co., Ltd. and Executive Vice Chairman of the Dietary Supplement Review Board. His research spans cholinergic compounds, antioxidants, and bioflocculants. Recognized with multiple awards, he continues to shape food science and regulatory policies. πŸ†

Publication Profile

Scopus

πŸŽ“ Academic Background

Prof. Dr. Young Jun Kim holds a Ph.D. in Food Science πŸ₯Ό from Cornell University (2001), where his research focused on the production of conjugated linoleic acids (CLA) by rumen bacteria 🦠 and their enhancement in dairy products πŸ₯›. He earned his M.S. in Food Science and Technology from Korea University (1996), investigating bioflocculant production by Corynebacterium sp. K-199 πŸ§ͺ. His academic journey began with a B.S. in Food Biotechnology from Korea University (1994), where he developed expertise in biotechnological applications in food science 🍽️. His research has significantly contributed to nutrition and functional food innovations. πŸš€

πŸ”¬ Research Experience

Prof. Dr. Young Jun Kim has an extensive research background in food science, biotechnology, and functional compounds πŸ§ͺ. As a Visiting Professor at the University of Saskatchewan (2023–2024), he explored cholinergic compounds for health, muscle strength improvement πŸ’ͺ, and Ξ±-GPC functionality. His postdoctoral research at Cornell University (2002–2004) involved cellulosome construction and polyphenol recovery from apple peel 🍏. He also worked on Arg-CLA’s antioxidant and anticancer properties at Seoul National University (2002). Earlier, at Boyce Thompson Institute, he contributed to edible vaccine development πŸ₯. His graduate research at Cornell and Korea University focused on CLA-enriched dairy πŸ₯› and bioflocculants for wastewater treatment. 🌿

πŸ† Honors and Awards

Prof. Dr. Young Jun Kim has received numerous prestigious awards for his contributions to food science and nutrition πŸ§ͺ. He was honored with the Minister of Science and ICT Commendation (2023) for fulfilling national R&D missions and received the Best Paper Award at the Korean Society of Food and Nutrition Science Conference (2023) πŸ“œ. His contributions to public health and nutrition earned him recognition from the U.S. Secretary of Health and Human Services (2021) πŸ‡ΊπŸ‡Έ. He has also been listed in Marquis Who’s Who in Medicine and Healthcare (2009–2010) and won multiple research and lecture awards from Cornell University, Korea University, and IFT πŸŽ“.

πŸ”¬ Research Focus

Prof. Dr. Y.J. Kim specializes in food science, nutrition, and bioactive compounds πŸ₯—πŸ§ͺ. His research explores functional foods, fermentation, antioxidants, and muscle atrophy prevention. Recent studies focus on Arriheuk wheat sprout extract for muscle health, Ξ±-Glycerylphosphorylcholine production in fermented foods, and anti-inflammatory effects of barley sprout fermentation 🌱. Additionally, he investigates sleep-enhancing compounds, food sensory optimization, and bioactive extracts from plants 🍏🌿. His expertise extends to flavor chemistry, browning prevention in fresh produce, and interleukin inhibition for health applications πŸ₯. His work significantly contributes to nutritional science and functional food development.

Publication Top Notes

  • Suppressive Effects of Arriheuk Wheat Sprout Extract on Muscle Atrophy in Dexamethasone-Induced C2C12 Myotubes and a Mouse Model
    Year: 2024 🧬
  • Production of Ξ±-Glycerylphosphorylcholine in Fermented Roots, Tubers, and Fruits
    Year: 2024 🍠
  • UP165, Standardized Corn Leaf Extract and its Active Component 6-Methoxybenzoxazolinone Induce Non-Rapid Eye Movement Sleep through Melatonergic and GABAergic Mechanisms
    Year: 2024 🌿
  • Characterization of Taste and Aroma Profile in Pomegranate (Punica Granatum L.) Seed Oil Using Electronic Sensors, GC-MS/Olfactometry
    Year: 2024 🍎
  • Validation of Optimization Methods for Sensory Characteristics Using Rate-All-That-Apply and Intensity Scales: A Case Study of Apple Juice
    Year: 2024 🍏
  • Antioxidant Activity of Extracts of Balloon Flower Root (Platycodon Grandiflorum), Japanese Apricot (Prunus Mume), and Grape (Vitis Vinifera) and Their Effects on Beef Jerky Quality
    Year: 2024 πŸ‡
  • Prediction Model of Browning Inhibitor Concentration and its Optimal Composition for Mass Processing of Ready-to-Eat Fresh-Cut β€˜Fuji’ Apple (Malus Domestica Borkh.) Strains
    Year: 2024 🍏
  • Identification of Interleukin (IL)-33 Inhibitory Constituents from Canavalia Gladiata Pods
    Cited by: 0
    Year: 2024 🌿
  • The Inhalation Effect of Osmanthus Fragrans var. Aurantiacus on Physiological Parameters in Chronically Stressed Rats
    Cited by: 1
    Year: 2024 🌸
  • Anti-Inflammatory Effects of Barley Sprout Fermented by Lactic Acid Bacteria in RAW264.7 Macrophages and Caco-2 Cells
    Cited by: 3
    Year: 2024 🌾

Dr Ashwin Kuchekar | Pharmaceutics | Best Researcher Award

Published on by Global Academic Awards

Ashwin Kuchekar | Pharmaceutics | Best Researcher Award

Professor Ashwin Kuchekar School of Health Sciences and Technology at India.

Dr. Ashwin Kuchekar is the Associate Dean (Academic and Faculty Affairs) and a Professor at the School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune. With extensive experience in both academia and industry, he focuses on enhancing research, management, and administration within the pharmaceutical sector. His expertise spans pharmaceutical formulation, development, and quality by design. Dr. Kuchekar is committed to bridging the gap between industry and academia through innovative teaching and robust industry partnerships.

PUBLICATION PROFILE:

google scholar

Education:

  • Ph.D. in Pharmaceutics (Pharmaceutical Sciences)
    Bharati Vidyapeeth University, Pune, India (2010-2015)
    Dissertation: Development and Evaluation of Targeted Polymeric Micellar Drug Delivery System
    Guide: Prof. Atmaram Pawar
  • Master of Pharmacy (Pharmaceutics)
    R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur, North Maharashtra University, India (2009)
    Dissertation: Formulation and Evaluation of Chronotherapeutic Drug Delivery Systems
    Guide: Dr. Surendra Gattani
  • Bachelor of Pharmacy
    Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, India (2007)
  • HSC
    Sadguru Gadge Maharaj College, Vidyanagar, Karad, Kolhapur Board, India (2003)
  • SSC
    Holy Family Convent High School, Vidyanagar, Karad, Kolhapur Board, India (2001)

Experience:

  • Associate Dean (Academic and Faculty Affairs) & Professor
    Dr. Vishwanath Karad MIT World Peace University, Pune (June 2023 – Present)
    Responsibilities include teaching B. Pharm. and M. Pharm. students, guiding research projects, managing the pilot plant, and overseeing training, placement, and industry partnerships.
  • Associate Professor
    Dr. Vishwanath Karad MIT World Peace University, School of Pharmacy, Pune (June 2019 – June 2023)
  • Lecturer – Pharmaceutics
    Progressive Education Society’s, Modern College of Pharmacy (For Ladies), Moshi, Pune (Nov 2009 – Aug 2010)
  • Industrial Experience:
    Innovation and Development at Abbott Healthcare Pvt. Ltd., Mumbai (Sep 2016 – Jun 2019)
    Formulation and Development at Lupin Research Park, Pune (Aug 2014 – Sep 2016)
    Formulation and Development at Piramal Health Care, Mumbai (May 2009 – Nov 2009)
    Formulation and Development at Nu-Life Pharmaceuticals, Pune (May 2006 – Jun 2006)

Research Focus:

Dr. Ashwin Kuchekar’s research is dedicated to advancing the field of pharmaceutics with a focus on innovative drug delivery systems and formulation development. His work encompasses a range of topics within pharmaceutical sciences, emphasizing the creation of novel technologies and methodologies to improve therapeutic efficacy and patient outcomes. Key areas of his research include:

  • 1. Drug Delivery Systems
  • Dr. Kuchekar explores cutting-edge methods for optimizing drug delivery, including:
  • Orally Disintegrating Tablets: Development and evaluation of tablets that rapidly dissolve in the mouth, enhancing patient compliance.
  • Nanoparticle-Based Delivery: Use of nanoparticles to improve the solubility and bioavailability of drugs, and to target specific sites within the body.
  • 2. Innovative Formulation Technologies
  • His research investigates novel formulation techniques to address challenges in pharmaceutical development, such as:
  • Cocrystallization: Enhancing drug properties through the formation of cocrystals to improve solubility and stability.
  • Hydrotropic Solubilization: Using hydrotropic agents to increase the solubility of poorly soluble drugs.
  • 3. Anticoagulant Research
  • Dr. Kuchekar has made significant contributions to the field of anticoagulants, including:
  • In Vivo Evaluation: Assessing the anticoagulant activity of new formulations and technologies to improve treatment outcomes for patients at risk of thromboembolic events.
  • 4. Green and Sustainable Chemistry
  • He focuses on environmentally friendly approaches, such as:
  • Green Synthesized Nanoparticles: Development of silver nanoparticles using plant extracts, contributing to sustainable practices in pharmaceutical research.
  • 5. Pediatric Drug Delivery
  • Dr. Kuchekar is also involved in research aimed at improving drug delivery systems for pediatric patients, addressing unique challenges in formulation and administration.
  • Dr. Kuchekar’s work is characterized by its emphasis on practical, real-world applications of pharmaceutical science, aiming to bridge the gap between research innovations and clinical practice to benefit patients and healthcare providers alike.

Research Interests:

  • Pharmaceutics and Drug Delivery Systems: Development and optimization of novel drug delivery systems, including targeted and controlled-release formulations. This includes the use of polymeric micelles, cocrystallization technology, and chronotherapeutic systems to improve drug efficacy and patient compliance.
  • Nanotechnology in Medicine: Application of nanotechnology in pharmaceutical formulations, such as green synthesis of nanoparticles for therapeutic use, and the development of dry powder inhalers.
  • Anticoagulant and Cardiovascular Drugs: Research on the formulation and evaluation of anticoagulant drugs, including the development of innovative dosage forms like matrix tablets and cocrystals to enhance their therapeutic potential.
  • Oncology: Exploration of new treatment strategies for various cancers, including triple-negative breast cancer, focusing on novel therapeutic approaches and their mechanisms of action.
  • Precision Medicine: Implementation of precision medicine approaches in the treatment of allergic rhinitis and other conditions, emphasizing individualized therapy based on patient-specific factors.
  • Skin Rejuvenation and Retinoids: Study of novel drug delivery systems for retinoids to improve skin rejuvenation and address age-related skin changes.
  • mRNA Vaccine Development: Investigation of lipid nanoparticles and other delivery systems in the development and optimization of mRNA vaccines for infectious diseases and other medical applications.

Publications:

  1. Formulation and evaluation of optimized oxybenzone microsponge gel for topical delivery
  2. Pharmaceutical Quality by Design: A new approach in product development
  3. Screening of factors using Plackett Burman design in the preparation of capecitabine-loaded nano polymeric micelles
  4. Six sigma: process of understanding the control and capability of ranitidine hydrochloride tablet
  5. Self microemulsifying drug delivery system: a novel approach for hydrophobic drugs
  6. Emulgel approach to formulation development: a review
  7. Capecitabine loaded polymeric micelles: Formulation, characterization and cytotoxicity study
  8. Development of ranolazine loaded floating biomaterial gellan beads using Box-Behnken factorial designHydrotropic solubilization: an emerging approach
  9. Hydrotropic solubilization: an emerging approach
  10. Polymeric micelles: a novel approach towards nano-drug delivery system

Nastaran Heydarikhayat | Health Professions Award | Best Researcher Award

Published on by Global Academic Awards

Dr. Nastaran Heydarikhayat | Health Professions Award | Best Researcher Award

Dr. Nastaran Heydarikhayat, Iranshahr University of Medical Sciences, Iran

Dr. Nastaran Heydarikhayat is a distinguished faculty member at Iranshahr University of Medical Sciences, specializing in nursing with extensive expertise in patient safety and burn survivor care. With a doctorate from Shahid Beheshti University, her research spans qualitative studies in nursing, including the impact of COVID-19 on healthcare professionals and home care efficacy for burn survivors. Dr. Heydarikhayat has authored numerous articles in reputable journals and collaborated internationally on healthcare innovations. Recognized for her contributions, she continues to lead impactful research projects, demonstrating dedication to advancing nursing education and patient care. 🌐✨

 

Publication profile

Google Scholar

Academic and Professional Background

With a Ph.D. in nursing from Shahid Beheshti University, Heydarikhayat’s career includes impactful research on patient safety and burn survivor care. πŸ₯

 

Research Focus

Nastaran Heydarikhayat’s research spans diverse areas within nursing, emphasizing qualitative and quantitative studies focused on patient care and healthcare systems. πŸ₯ Her notable contributions include studies on burn survivor care, patient safety, and the psychological impacts of home care interventions. Through extensive clinical trials and qualitative analyses, Heydarikhayat has explored topics such as nurse-patient interactions during triage, coping strategies among medical students, and the lived experiences of nurses caring for COVID-19 patients. Her work not only enhances understanding in these critical areas but also contributes significantly to improving healthcare practices and policies. 🌟

 

Publication Top Notes

Piotr Fiedor | Medicinal products | Academic Excellence in Entrepreneurship Award

Published on by Global Academic Awards

Prof Dr. Piotr Fiedor | Medicinal products | Academic Excellence in Entrepreneurship Award

Prof Dr. Piotr Fiedor, Piotr Fiedor, Professor of Surgery, Warsaw Medical University, Dept. of General and Transplantation Surgery, Poland

Prof. Dr. Piotr Fiedor, MD, PhD is a distinguished surgeon and academic with extensive expertise in general surgery, oncology, transplant immunology, and medical research. Since 1995, he has served at the Department of General and Transplantation Surgery, Warsaw Medical University. 🌟 He has held pivotal roles such as CEO of the National Medicines Institute and a member of the European Medicines Agency’s CHMP. 🌍 Dr. Fiedor has been involved in over 210 scientific papers and numerous prestigious projects, contributing significantly to the fields of biotechnology and personalized medicine. πŸ“šπŸ† His accolades include Poland’s “Gold Cross of Merit” and numerous scientific awards. πŸ…

 

Publication Profile

Scopus

Education πŸŽ“

Professor Piotr Fiedor completed a prestigious fellowship in transplantation immunology and immunomodulation at the College of Physicians and Surgeons, Columbia University, USA, from 1993 to 1996. He further enhanced his medical expertise through a clinical oncology internship at the Institute-Center of Oncology between 2006 and 2008.

Teaching Experience πŸŽ“

From 1986 to 2005, Professor Piotr Fiedor served as an Adjunct and Associate Professor of Surgery at Warsaw Medical University. His teaching focus encompassed general medicine, transplantation, and oncology, significantly contributing to the academic growth of numerous medical students.

Administrative Experience πŸ₯

Since 2015, Dr. Fiedor has been the Chief Executive Officer of the National Medicines Institute in Warsaw, overseeing the quality control of medicinal products. His previous administrative roles include harmonization and registration expertise at The Office for Registration of Medicinal Products (2007-2010) and leadership in clinical trials inspection at the National Institute of Health (1997-2001).

Awards and Honours πŸ…

Dr. Fiedor’s accolades include the “Gold Cross of Merit” (2011) and the “Silver Cross of Merit” (2005) awarded by the President of Poland. He has also received the first-degree team teaching award (2012) for co-authoring a textbook on disaster medicine and numerous team science awards for his significant contributions to medical research and education.

 

Research Focus πŸ”¬

Professor Piotr Fiedor’s research is predominantly focused on transplantation medicine, immunology, and oncology. His recent works include investigating the educational and therapeutic support for rare disease transplant recipients and studying long-term outcomes of surgical treatments in immunocompromised patients. He has also contributed significantly to COVID-19 research, exploring the effects of amantadine on unvaccinated patients and the analysis of pathological changes in COVID-19 imaging databases. His interdisciplinary research extends to dermatological therapies and chronic wound treatments, showcasing a commitment to improving patient outcomes across various medical fields. 🌟

Publication Top Notes